Exploring Investment Opportunities with (ASX:JHX) and (ASX:CSL) in 2025

2 min read | April 01, 2025 09:58 PM AEDT | By Team Kalkine Media

Google News:

Exploring Investment Opportunities with (ASX:JHX) and (ASX:CSL) in 2025 — Image source: Shutterstock

Recent News

Rare Earths' Next Trigger: What the Market May Be Missing

Rare Earth Stocks Are Stirring Again — But What’s Really Changed?

ASX Penny Stocks: Where the Next Market Story Could Emerge

Hidden Signals Fueling the Next Wave of ASX Penny Stocks

Make Kalkine Media
My Trusted Source

Highlights

Explore the potential of (ASX:JHX) and (ASX:CSL) shares

Insights into (ASX:JHX)'s growth metrics and product offerings

Overview of (ASX:CSL)'s robust business units and financial health

Despite recent fluctuations in their share prices, James Hardie Industries plc (JHX) and CSL Ltd (ASX:CSL) continue to draw attention in the Australian Securities Exchange (ASX). This article delves into why these companies might be notable mentions for investors keeping an eye on future growth opportunities.

(ASX:JHX), a global leader in building solutions, is renowned for being the world's largest producer of fibre cement and gypsum products. The company, employing over 5,200 individuals, operates across North America, Europe, Australia, and New Zealand. The choice of fibre cement is particularly favored in the building materials sector due to its resistance to fire, water, and termites, alongside its durability and low maintenance needs. From 2021, (JHX) has shown impressive financial growth with a revenue increase at an annual rate of 10.6%, leading to a net profit jump from $263 million to $510 million in FY24. The company also boasts a strong Return on Equity (ROE) of 29.4%.

On the other hand, (CSL), initially a governmental entity, has transformed into a leading global biotechnology company. It operates through three main business units: CSL Behring, CSL Seqirus, and CSL Vifor. CSL Behring is known for its blood plasma products, while CSL Seqirus focuses on flu-related products and services, including pandemic responses for governments. CSL Vifor tackles health issues related to iron deficiency and nephrology. With a longstanding reputation as a reliable performer and a consistent dividend payer, (CSL) maintains high investor interest, supported by a debt/equity ratio of 62.8% in FY24 and an average dividend yield of 1.5% since 2020. The company also recorded a solid ROE of 14.6% in FY24, underscoring its financial stability.

As investors evaluate these companies, it's crucial to consider the varying dynamics of growth versus maturity. While (JHX) presents itself as a rapidly expanding entity, (CSL) represents a more mature investment, offering stability and consistent returns. Both companies offer unique aspects worth watching, whether one is interested in the robust growth of building materials or the steady advancement in biotechnology.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.